Drug Type Aptamer drug conjugates |
Synonyms RBM 006, RBM-006 |
Target |
Action inhibitors |
Mechanism autotaxin inhibitors(Ectonucleotide pyrophosphatase/phosphodiesterase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetic Retinopathy | Preclinical | Japan | 01 Dec 2025 | |
| Glaucoma | Preclinical | Japan | 01 Dec 2025 | |
| Vitreoretinopathy, Proliferative | Preclinical | Japan | 01 Dec 2025 | |
| Idiopathic Pulmonary Fibrosis | Preclinical | Japan | - | |
| Liver Cirrhosis | Preclinical | Japan | - | |
| Scleroderma, Systemic | Preclinical | Japan | - |





